Xueyi Pan
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Efficacy of eltrombopag in combination with recombinant human thrombopoietin (rhTPO) for lymphoma patients with chemotherapy-induced thrombocytopenia.
Journal: Frontiers in pharmacology
Published: May 12, 2026
Lamotrigine-Induced Hemophagocytic Lymphohistiocytosis with DRESS.
Journal: Clinical laboratory
Published: February 12, 2024
The successful treatment of Enterocytozoon bieneusi Microsporidiosis with nitazoxanide in a patient with B-ALL: A Case Report.
Journal: Frontiers in cellular and infection microbiology
Published: October 17, 2022
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma.
Journal: Thrombosis journal
Published: October 15, 2022
Modified DEP regimen as induction therapy for lymphoma-associated hemophagocytic lymphohistiocytosis: a prospective, multicenter study.
Journal: Journal of cancer research and clinical oncology
Published: May 03, 2022
The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Journal: Journal of cancer research and clinical oncology
Published: April 22, 2022
IL-6 and IL-10 Are Associated With Gram-Negative and Gram-Positive Bacteria Infection in Lymphoma.
Journal: Frontiers in immunology
Published: January 16, 2022
A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia.
Journal: Frontiers in oncology
Published: April 28, 2021
Education level as a predictor of survival in patients with multiple myeloma.
Journal: BMC cancer
Published: March 14, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026